These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10319938)

  • 1. Increased serum soluble Fas in patients with Graves' disease.
    Hiromatsu Y; Bednarczuk T; Soyejima E; Miyake I; Yang D; Fukazawa H; Nonaka K
    Thyroid; 1999 Apr; 9(4):341-5. PubMed ID: 10319938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentration of soluble Fas in patients with autoimmune thyroid diseases.
    Shimaoka Y; Hidaka Y; Okumura M; Takeoka K; Tada H; Amino N
    Thyroid; 1998 Jan; 8(1):43-7. PubMed ID: 9492152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating nuclear matrix protein in Graves' disease.
    Hara H; Morita Y; Sato R; Ban Y
    Endocr J; 2002 Jun; 49(3):343-7. PubMed ID: 12201219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
    Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
    Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increased serum soluble Fas ligand in hyperthyroid Graves' disease].
    Takeda K; Ohara E; Kaneda T; Hashimoto K; Sasaki M
    Rinsho Byori; 1999 Oct; 47(10):961-5. PubMed ID: 10590671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Fas ligand expression in thyrocytes from patients with Graves' disease.
    Hiromatsu Y; Hoshino T; Yagita H; Koga M; Sakisaka S; Honda J; Yang D; Kayagaki N; Okumura K; Nonaka K
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2896-902. PubMed ID: 10443697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased serum level of IL-7 in patients with active Graves' disease.
    Motylewska E; Nieć M; Siejka A; Komorowski J; Ławnicka H; Świętosławski J; Stępień H
    Cytokine; 2015 Oct; 75(2):373-9. PubMed ID: 26113403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis.
    Fountoulakis S; Vartholomatos G; Kolaitis N; Frillingos S; Philippou G; Tsatsoulis A
    Eur J Endocrinol; 2008 Jun; 158(6):853-9. PubMed ID: 18505906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased serum concentrations of interleukin-6 (IL-6) and soluble IL-6 receptor in patients with Graves' disease.
    Salvi M; Girasole G; Pedrazzoni M; Passeri M; Giuliani N; Minelli R; Braverman LE; Roti E
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2976-9. PubMed ID: 8768861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The value of estimating serum aproptotic marker concentrations in monitoring and prognosis of 131I--therapy in Graves' disease. Preliminary report.
    Rogowski F; Parfieńczyk A; Sopotyk A; Budlewski T; Jabłońska E; Kiersnowska-Rogowska B; Szumowski P
    Nucl Med Rev Cent East Eur; 2004; 7(2):117-22. PubMed ID: 15968597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating soluble Fas ligand correlates with disease activity in Graves' hyperthyroidism.
    Wang CY; Zhong WB; Chang TC; Tsai YF
    Metabolism; 2002 Jun; 51(6):769-73. PubMed ID: 12037733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Chrousos GP; Koutras DA
    Thyroid; 2000 Jul; 10(7):527-32. PubMed ID: 10958304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of IL-37 in patients with Graves' disease and its contribution to suppression of proinflammatory cytokines production in peripheral blood mononuclear cells.
    Li Y; Wang Z; Yu T; Chen B; Zhang J; Huang K; Huang Z
    PLoS One; 2014; 9(9):e107183. PubMed ID: 25226272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum Fas in patients with Graves' ophthalmopathy as a marker of activity of the ocular inflammatory infiltration].
    Myśliwiec J; Kretowski A; Stepień A; Okłota M; Kinalska I
    Pol Merkur Lekarski; 2004 Oct; 17(100):368-70. PubMed ID: 15690704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones.
    Morikawa Y; Morikawa A; Makino I
    J Clin Endocrinol Metab; 1993 Mar; 76(3):609-14. PubMed ID: 7680353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers.
    Myśliwiec J; Okota M; Nikołajuk A; Górska M
    Adv Med Sci; 2006; 51():119-22. PubMed ID: 17357290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of soluble Fas in the serum of patients with bladder cancer.
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):571-6. PubMed ID: 9679930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the IL-23/IL-17 axis in the pathogenesis of Graves' disease.
    Zheng L; Ye P; Liu C
    Endocr J; 2013; 60(5):591-7. PubMed ID: 23327801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.